Prophylactic antiepileptic treatment reduces seizure frequency in natalizumab-associated progressive multifocal leukoencephalopathy

10Citations
Citations of this article
19Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

Little is known about seizures in natalizumab-associated progressive multifocal leukoencephalopathy (NAT-PML). Methods: A review of clinical records of 15 NAT-PML patients with multiple sclerosis (MS) treated at a German university hospital. Results: Some 53% (8/15) of our patients developed seizures with often multiple semiologies (seven grand mal, three simple partial motor and two psychomotor seizures). Series of seizures or status epilepticus occurred in seven of these eight. Seizure onset was on average 61 days after onset of NAT-PML and was associated with immune reconstitution inflammatory syndrome (IRIS) in five of eight patients. After having observed severe seizures during NAT-PML in seven of our first nine patients, we started preventive antiepileptic treatment (PAT) with levetiracetam (1000–1750 mg/day). Patient subgroups analyzed for seizures and PAT did not differ in baseline characteristics. Only one of six patients, who received PAT, had a seizure compared with seven of nine patients without PAT (2-tailed Fisher's exact test, p = 0.04). Although the small sample size and retrospective nature of the study are limitations, we propose to treat NAT-PML patients with PAT early after diagnosis, as seizures seem to be common and severe in NAT-PML. © 2013, SAGE Publications. All rights reserved.

References Powered by Scopus

Natalizumab-associated progressive multifocal leukoencephalopathy in patients with multiple sclerosis: lessons from 28 cases

574Citations
N/AReaders
Get full text

Identification and characterization of mefloquine efficacy against JC virus in vitro

208Citations
N/AReaders
Get full text

Progressive multifocal leukoencephalopathy and other forms of JC virus disease

180Citations
N/AReaders
Get full text

Cited by Powered by Scopus

Progressive multifocal leukoencephalopathy and immune reconstitution inflammatory syndrome (IRIS)

51Citations
N/AReaders
Get full text

Clinical/Scientific Notes: Progressive multifocal leukoencephalopathy during fumarate monotherapy of psoriasis

25Citations
N/AReaders
Get full text

Pathologic Findings of Chronic PML-IRIS in a Patient with Prolonged PML Survival Following Natalizumab Treatment

10Citations
N/AReaders
Get full text

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Cite

CITATION STYLE

APA

Hoepner, R., Dahlhaus, S., Kollar, S., Zurawski, B., Chan, A., Kleiter, I., … Hellwig, K. (2014). Prophylactic antiepileptic treatment reduces seizure frequency in natalizumab-associated progressive multifocal leukoencephalopathy. Therapeutic Advances in Neurological Disorders, 7(1), 3–6. https://doi.org/10.1177/1756285613503515

Readers' Seniority

Tooltip

PhD / Post grad / Masters / Doc 6

43%

Researcher 6

43%

Professor / Associate Prof. 2

14%

Readers' Discipline

Tooltip

Medicine and Dentistry 9

64%

Neuroscience 2

14%

Agricultural and Biological Sciences 2

14%

Pharmacology, Toxicology and Pharmaceut... 1

7%

Save time finding and organizing research with Mendeley

Sign up for free